FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Duke Clinical Research Institute
Durham, Estados UnidosPublicaciones en colaboración con investigadores/as de Duke Clinical Research Institute (5)
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529
2017
-
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
Journal of the American Heart Association, Vol. 6, Núm. 7
2015
-
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 373, Núm. 3, pp. 232-242
2011
-
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy
Journal of Infectious Diseases, Vol. 203, Núm. 11, pp. 1629-1636
2010
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
Clinical Infectious Diseases, Vol. 51, Núm. 10, pp. 1209-1216